Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity (Q39380204)

11 September 2017

title

Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity (English)

1 reference

11 September 2017

0 references

Shuli Zhao

1

1 reference

11 September 2017

Huijuan Wang

2

1 reference

11 September 2017

Yunzhong Nie

3

1 reference

11 September 2017

Qiongyu Mi

4

1 reference

11 September 2017

Xingguo Chen

5

1 reference

11 September 2017

Yayi Hou

6

1 reference

11 September 2017

publication date

14 March 2012

1 reference

Cancer Immunology, Immunotherapy

11 September 2017

published in

1 reference

11 September 2017

volume

61

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

1745-1753

1 reference

11 September 2017

cites work

NKG2D and its ligands

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Roles of the NKG2D immunoreceptor and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Proteolytic release of soluble UL16-binding protein 2 from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Midkine translocated to nucleoli and involved in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

siRNA targeting midkine inhibits gastric cancer cells growth and induces apoptosis involved caspase-3,8,9 activation and mitochondrial depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Soluble MICA in malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1235-3

10.1007/S00262-012-1235-3

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference